文献速递神经创伤神经重症

重型创伤性脑损伤后亚急性期代谢与血液学标志物趋势可预测长期预后

Subacute Trends in Metabolic and Hematological Markers Days After Severe Traumatic Brain Injury Predict Long-Term Outcomes.
PubMed 文献 · Neurosurgery · 2025-11-25

这项单中心前瞻性队列研究纳入315例重型创伤性脑损伤患者,分析伤后14天内代谢与血液学标志物的波动,并关联伤后6个月扩展格拉斯哥结局量表评分。研究发现,亚急性期生物标志物趋势使预测模型性能提升8%(R²从约19%升至27%),葡萄糖、钠和血小板的波动模式与最终结局显著相关。

要点

  • 伤后14天内葡萄糖、钠、血小板波动模式一致,与6个月功能结局相关。
  • 纳入亚急性期标志物趋势使预测模型R²从约19%提升至27%。
  • 部分患者中葡萄糖和血小板波动与入院48小时内皮质醇水平相关。

核心结论

  • 重型TBI后数天至数周内血液学和代谢标志物的波动形成一致模式,可关联内分泌紊乱和6个月功能结局。

研究设计与样本

  • 单中心I级创伤中心前瞻性队列研究,纳入315例重型TBI患者,从入院至伤后14天定期测量生命体征、动脉血气、基础代谢面板、血细胞计数和内分泌面板,以伤后6个月GOSE定义功能结局,采用随机森林回归树关联标志物与结局。

主要发现

  • IMPACT模型预测6个月GOSE的决定系数(R²)约为19%。
  • 纳入亚急性期生物标志物趋势后模型性能提升8%(R²=27%)。
  • 入院后前2周葡萄糖、钠和血小板的波动在参与者中形成可靠模式,并与最终结局显著相关(钠和葡萄糖相关系数为-0.3至-0.4,血小板为+0.2至+0.3)。
  • 在部分参与者中,葡萄糖和血小板波动与入院48小时内皮质醇水平相关。

临床怎么用

  • 对重型TBI患者,伤后亚急性期动态监测葡萄糖、钠和血小板趋势可能有助于长期功能预后判断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Prognostic models for severe traumatic brain injury (TBI) patients do not perform well enough to be clinically useful, possibly because included predictors for the most well-established models are from hospital presentation only. We sought to investigate fluctuations in metabolic and hematological markers over the subacute time period (ie, up to 14 days postinjury) and associate these changes with functional outcome at 6 months postinjury. METHODS: This cohort study included prospectively collected patients with severe TBI treated at a single level I trauma center (n = 315). Measured metrics included basic vitals (eg, heart rate), arterial blood gases, basic metabolic panel (eg, glucose, sodium), blood counts (eg, hemoglobin, platelets), and endocrine panels (eg, cortisol) taken periodically from admission to 14 days postinjury. Functional outcome was defined as Glasgow Outcome Scale-Extended score at 6 months. Random forest regression trees were used to associate these markers to outcome. Model performance was compared to using International Mission on Prognosis and Analysis of Clinical Trials metrics collected on hospital admission. RESULTS: The International Mission on Prognosis and Analysis of Clinical Trials model predicted 6-month Glasgow Outcome Scale-Extended with a coefficient of determination (R 2 ; ie, variance accounted for) of approximately 19%. Incorporation of subacute biomarker trends improved model performance by 8% (R 2 = 27%). Fluctuations in glucose, sodium, and platelets over the first 2 weeks postadmission formed reliable patterns across participants and correlated significantly with eventual outcomes (correlation = -0.3 to -0.4 for sodium and glucose, correlation = +0.2 to +0.3 for platelets). In a subset of participants, fluctuations in glucose and platelets were associated to cortisol levels taken within 48 hours of admission. CONCLUSION: Fluctuations in several hematological and metabolic markers over the days to weeks after severe TBI form consistent patterns that can be linked to endocrinological disruptions and 6-month functional outcome.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Eagle SR, Wang M, Shanahan RM, et al. Subacute Trends in Metabolic and Hematological Markers Days After Severe Traumatic Brain Injury Predict Long-Term Outcomes. Neurosurgery. 2025. PMID: 41288377. doi:10.1227/neu.0000000000003863

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。